Recruiting

APS Detect

Sponsor:

Schweitzer Engineering Laboratories

Code:

NCT07903675

Conditions

Autism Spectrum Disorder

Eligibility Criteria

Sex: All

Age: 2 - 5

Healthy Volunteers: Accepted

Interventions

Autism Pupil Screen (APS) Detect PLR Assessment #1

Modified Checklist for Autism in Toddlers, Revised with Follow-up (M-CHAT/R-F)

Social Responsiveness Scale, Second Edition (SRS-2)

Autism Diagnostic Observation Schedule, Second Edition (ADOS-2)

Mullen Scales of Early Learning (MSEL)

Study Details

Brief summary:

Autism spectrum disorder (ASD) is a developmental condition that can affect communication, social interaction, and behavior. Identifying ASD early helps children and families access support services sooner. Pupillometry is a way of measuring the nervous system and brain function by recording the pupil response to light. It is a non-invasive technology that may support screening practices by providing health care providers with an objective physical measure to bolster behavioral screening tools used to identify children with ASD .

This study is evaluating how well the APS Detect™ handheld pupillometer works to help screen for ASD in children 2 to 4 years of age during routine pediatric healthcare visits. This investigational device measures the child's pupil response to light and uses these measurements to estimate the likelihood of ASD.

Researchers will compare screening results using the APS Detect with the results of reference standard clinical assessments used to determine whether a child has autism. The study will assess how accurately the device identifies children with autism compared to children with typical development based on the Autism Pupil Screen (APS) score.

The study will also evaluate whether the device provides the same results when used by different healthcare professionals. Information collected during this study will be used to evaluate device performance, safety, and suitability for use in pediatric healthcare settings and may support future review by the U.S. Food and Drug Administration (FDA).

Conditions

Autism Spectrum Disorder

Study ID

NCT07903675

Start date

Oct 23, 2026

Status verified date

Oct, 2026

Completion date

Apr 30, 2027

Anticipated

Primary completion date

Apr 16, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 2 - 5

Healthy Volunteers: Accepted

Inclusion Criteria:

Children between 24 months and 60 months of age

Exclusion Criteria:

Children with a prior diagnosis of ASD Children experiencing a seizure within the past 6 months prior to the first day of testing Children that have experienced head trauma Children that have hearing loss or vision loss corrected or uncorrected that impacts their daily life Children that had any known exposure to alcohol, drugs, prescription medications, or environmental toxins before or after birth

Study Design

Enrollment

330 participants

Anticipated

Interventions and Outcome Measures

Arms

Arm A - Autism Spectrum Disorder (ASD)

Participants with Autism Spectrum Disorder (ASD) within Arm A

Arm A - Typical Development (TD) - Not ASD

Participants without Autism Spectrum Disorder (ASD) within Arm A

Arm B - Autism Spectrum Disorder (ASD)

Participants with Autism Spectrum Disorder (ASD) within Arm B Precision Sub-study

Arm B - Typical Development (TD) - Not ASD

Participants without Autism Spectrum Disorder (ASD) within Arm B Precision Sub-study

Interventions

Autism Pupil Screen (APS) Detect PLR Assessment #1

The APS Detect™ is an investigational handheld pupillometer that measures pupillary light reflex (PLR) responses using a brief, noninvasive assessment. Measurements obtained by the device are used to generate an Autism Pupil Screening (APS) score that is intended to help identify children who may be at risk for autism spectrum disorder (ASD) during routine pediatric healthcare visits. The APS Detect is investigational and has not been cleared by the U.S. Food and Drug Administration (FDA) for clinical use.

Modified Checklist for Autism in Toddlers, Revised with Follow-up (M-CHAT/R-F)

A validated parent- or caregiver-completed screening tool used to identify children who may be at risk for autism spectrum disorder (ASD). The questionnaire is designed for children between 16 and 30 months of age and consists of an initial screening questionnaire followed by a structured follow-up interview for children with positive screening results. The M-CHAT-R/F is intended to identify children who may benefit from further developmental and diagnostic evaluation for ASD.

Social Responsiveness Scale, Second Edition (SRS-2)

A standardized questionnaire used to measure the presence and severity of social communication difficulties and restricted or repetitive behaviors associated with autism spectrum disorder (ASD). The SRS-2 is completed by a parent, caregiver, teacher, or other knowledgeable respondent and provides quantitative scores that help assess social functioning and identify characteristics associated with ASD across a range of ages. It is intended to support the screening and evaluation of individuals who may have ASD and to monitor changes in social responsiveness over time.

Autism Diagnostic Observation Schedule, Second Edition (ADOS-2)

A standardized, play-based assessment administered by a trained clinician to evaluate social communication, social interaction, play, and restricted or repetitive behaviors associated with autism spectrum disorder (ASD). The ADOS-2 consists of age- and language-specific assessment modules and is widely used as part of a comprehensive diagnostic evaluation to support the identification and classification of ASD.

Mullen Scales of Early Learning (MSEL)

A standardized developmental assessment administered by a trained examiner to evaluate cognitive and developmental functioning in young children from birth through 68 months of age. The assessment measures visual reception, fine motor skills, receptive language, and expressive language and provides information about a child's developmental abilities relative to age-based expectations.

Adaptive Behavior Assessment System, Third Edition (ABAS-3)

A standardized assessment completed by a parent, caregiver, teacher, or other knowledgeable respondent to evaluate adaptive functioning in everyday life. The ABAS-3 measures skills across conceptual, social, and practical domains, including communication, self-care, social interaction, community use, and functional academics. Results provide an assessment of an individual's ability to perform age-appropriate daily activities and support the evaluation of developmental, intellectual, and behavioral functioning.

Autism Pupil Screen (APS) Detect PLR Assessment #2

The APS Detect™ is an investigational handheld pupillometer that measures pupillary light reflex (PLR) responses using a brief, noninvasive assessment. Measurements obtained by the device are used to generate an Autism Pupil Screening (APS) score that is intended to help identify children who may be at risk for autism spectrum disorder (ASD) during routine pediatric healthcare visits. The APS Detect is investigational and has not been cleared or approved by the U.S. Food and Drug Administration (FDA) for clinical use.

This intervention will be used for the second assessment with the APS Detect™ in Arm B, the precision sub-study to evaluate the reliability and reproducibility of the Autism Pupil Screening (APS) Detect™ investigational device.

Autism Pupil Screen (APS) Detect Assessment #3

The APS Detect™ is an investigational handheld pupillometer that measures pupillary light reflex (PLR) responses using a brief, noninvasive assessment. Measurements obtained by the device are used to generate an Autism Pupil Screening (APS) score that is intended to help identify children who may be at risk for autism spectrum disorder (ASD) during routine pediatric healthcare visits. The APS Detect is investigational and has not been cleared or approved by the U.S. Food and Drug Administration (FDA) for clinical use.

This intervention will be used for the third assessment with the APS Detect™ in Arm B, the precision sub-study to evaluate the reliability and reproducibility of the Autism Pupil Screening (APS) Detect™ investigational device.

Well-child check

A routine pediatric healthcare visit that includes assessment of growth, development, general health, and age-appropriate preventive care. The visit may include a physical examination, developmental surveillance, review of medical history, and discussion of health concerns with the child's parent or caregiver following the American Academy of Pediatrics (AAP) Bright Futures guidelines.

Primary outcome measure

  • Sensitivity and Specificity of the APS Score to classify ASD diagnostic outcome [ Time Frame: From enrollment to the end of all testing visits will be 14-30 days ]

Central Contacts and Locations

Locations

SEL Health Clinic - Lewiston

Recruiting

Lewiston, Idaho, United States, 83501

Contacts

Principal Investigator:

Keith Gautreaux, MD

Palouse Pediatrics

Recruiting

Moscow, Idaho, United States, 83843

Contacts

Principal Investigator:

Kathryn Hryniewicz, MD

Palouse Pediatrics

Recruiting

Pullman, Washington, United States, 99163

Contacts

Principal Investigator:

Kathryn Hryniewicz, MD

SEL Health Clinic - Pullman

Recruiting

Pullman, Washington, United States, 99163

Contacts

Principal Investigator:

Keith Gautreaux, MD

More Information

Sponsor

Schweitzer Engineering Laboratories

Last update posted

Oct 29, 2026

Last verified

Oct, 2026

Keywords

  • Autism Screening
  • Pupil Screening Autism
  • Early Identification
  • Medical Device
  • APS Detect

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-30. This information was provided to ClinicalTrials.gov by Schweitzer Engineering Laboratories on 2026-10-29. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.